Tian Zhang

Tian Zhang

Auto-generated profile, based on publicly available information

Tian Zhang

Division of Newborn Medicine, Department of Pediatrics Boston Children's Hospital, Harvard Medical School Boston Massachusetts USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2018 in Proteomics
Verified
Journal Article
Closed access
PDF file
MAMeasho H. Abreha
Measho H. Abreha
EDEric Dammer
Eric Dammer
LPLingyan Ping
Lingyan Ping
TZTian Zhang
Tian Zhang
DDDuc M. Duong
Duc M. Duong
NSNicholas T. Seyfried
Nicholas T. Seyfried

23 November 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TZTian Zhang
Tian Zhang
ZWZhejun Wang
Zhejun Wang
RHRobert E. W. Hancock
Robert E. W. Hancock
CFCésar de la Fuente-Núñez
César de la Fuente-Núñez
MHMarkus Haapasalo
Markus Haapasalo
Almost all dental diseases are caused by biofilms that consist of multispecies communities. DJK-5, which is a short D-enantiomeric, protease-resistant peptide with broad-spectrum anti-biofilm activity, was tested for its effect on oral multispecies biofilms. Peptide DJK-5 at 10 μg/mL effectively prevented the growth of these microbes in culture media in a time-dependent manner. In addition to the prevention of growth, peptide DJK-5 completely killed both Streptococcus mutans and Enterococcus faecalis suspended from biofilms after 30 minutes of incubation in liquid culture media. DJK-5 also led to the effective killing of microbes in plaque biofilm. The proportion of bacterial cells killed by 10 μg/mL of DJK-5 was similar after 1 and 3 days, both exceeding 85%. DJK-5 was able to significantly prevent biofilm formation over 3 days (P = 0.000). After 72 hours of exposure, DJK-5 significantly reduced and almost completely prevented plaque biofilm production by more than 90% of biovolume compared to untreated controls (P = 0.000). The proportion of dead biofilm bacteria at the 10 μg/mL DJK-5 concentration was similar for 1- and 3-day-old biofilms, whereby >86% of the bacteria were killed. DJK-5 was also able to kill >79% and >85% of bacteria, respectively, after one-time and three brief treatments of 3-day-old biofilms. The combination of DJK-5 and chlorhexidine showed the best bacterial killing among all treatments, with ~83% and >88% of bacterial cells killed after 1 and 3 minutes, respectively. No significant difference was found in the percentage of biofilm killing amongst three donor plaque samples after DJK-5 treatment. In particular, DJK-5 showed strong performance in inhibiting biofilm development and eradicating pre-formed oral biofilms compared to L-enantiomeric peptide 1018. DJK-5 was very effective against oral biofilms when used alone or combined with chlorhexidine, and may be a promising agent for use in oral anti-biofilm strategies in the future.

5 February 2020 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
ADAlissa M D'Gama
Alissa M D'Gama
WBWilliam J. Brucker
William J. Brucker
TZTian Zhang
Tian Zhang
CGCynthia S. Gubbels
Cynthia S. Gubbels
SFSacha Ferdinandusse
Sacha Ferdinandusse
PAPankaj Agrawal
Pankaj Agrawal

11 September 2020 in The American Journal of Pathology
Verified
Journal Article
Closed access
QLQifei Li
Qifei Li
JLJasmine Lin
Jasmine Lin
SRSamantha M. Rosen
Samantha M. Rosen
TZTian Zhang
Tian Zhang
SKShideh Kazerounian
Shideh Kazerounian
PAPankaj Agrawal
Pankaj Agrawal

2 August 2022 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
TZTian Zhang
Tian Zhang
JBJulie M. Briere
Julie M. Briere
KLKristen T. Leeman
Kristen T. Leeman
MWMonica Wojcik
Monica Wojcik
PAPankaj Agrawal
Pankaj Agrawal